# Voxy reviews (2026): GLP-1 telehealth sellers | This GLP The figure in the headline belongs to the twelve-month plan, and every other rung is published beside it. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/voxy Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Headline is the annual tier # Voxy review The figure in the headline belongs to the twelve-month plan, and every other rung is published beside it. ## The verdict Voxy publishes $179 a month for compounded semaglutide, with a headline of starting at $129 that belongs to the annual prepay tier. Every rung of the ladder is published. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection From From $179/mo Prescription Required Compounded Yes — not FDA-approved Voxy sells both molecules by injection across four billing cadences. The price covers the provider visit, medication, injection supplies, shipping and monthly check-ins. 1. ## Who writes the prescription, and what do they see? Monthly check-ins are named as included, which is a specific commitment about the clinical relationship rather than a general one. The clinician is not otherwise described. Five things inside one figure is a broad inclusion list, and monthly check-ins in particular are rare. The headline choosing the lowest rung is the usual pattern, and the other rungs being published beside it is not. 2. ## What happens when the dose goes up? Nothing states what any rung does at a higher dose. The ladder is about billing cadence rather than milligrams, so the escalation question is unanswered on all four rungs equally. 3. ## What the price includes Semaglutide runs $179 month to month, $159 billed quarterly, $149 billed every six months and $129 billed annually. Tirzepatide runs $299, $269, $239 and $199. The annual rung is 28 percent below the monthly on semaglutide and 33 percent on tirzepatide. 4. ## What it claims, and what it cites Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named. ## Where it holds up, and where it does not - Strength: All four cadences published - Strength: Monthly check-ins named as included - Strength: Visit, supplies and shipping inside the price - Limitation: The headline is the annual tier - Limitation: Month to month costs $50 more - Limitation: No dose behavior is published - Limitation: No state coverage list is recorded ## What the evidence says about this kind of treatment The assessment above is about Voxy. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A reader who wants check-ins included and will pick a cadence deliberately. Wrong for A reader planning monthly from the headline figure. ## The evidence behind what Voxy prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How Voxy compares | Seller | Who it suits | Go | | --- | --- | --- | | VitaStir | Readers who will price the rung they expect to reach rather than the entry one | | | Whoosh Wellness | Readers unsure of eligibility who do not want to risk a consultation fee | | | VyrarX | Readers who will ask what maintenance costs before starting | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [Superior Remedies](https://thisglp.com/reviews/superior-remedies) [Superpower](https://thisglp.com/reviews/superpower-health) [SurpassMD](https://thisglp.com/reviews/surpassmd) [SynergenX Health](https://thisglp.com/reviews/synergenx) [Synergy Rx](https://thisglp.com/reviews/synergy-rx) [T2D.com](https://thisglp.com/reviews/t2d) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked Is $129 a monthly rate? It is the twelve-month prepay tier. Month to month is $179 for semaglutide. What is included? The provider visit, medication, injection supplies, shipping and monthly check-ins. What are the middle rungs? $159 billed quarterly and $149 billed every six months on semaglutide. Is Voxy expensive compared with other GLP-1 telehealth sellers? Voxy publishes a starting figure of $179/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Voxy below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).